71020 Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices 

Dated: October 10, 2023. 

Melanie O’Brien, 

Manager, National NAGPRA Program. 

[FR Doc. 2023–22674 Filed 10–12–23; 8:45 am] 

BILLING CODE 4312–52–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–695–698 and 

731–TA–1643–1657 (Preliminary)] 

Aluminum Extrusions From China, 

Colombia, Dominican Republic, 

Ecuador, India, Indonesia, Italy, 

Malaysia, Mexico, South Korea, 

Taiwan, Thailand, Turkey, United Arab 

Emirates, and Vietnam; Institution of 

Antidumping and Countervailing Duty 

Investigations and Scheduling of 

Preliminary Phase Investigations 

AGENCY: International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: The Commission hereby gives 

notice of the institution of investigations 

and commencement of preliminary 

phase antidumping and countervailing 

duty investigation Nos. 701–TA–695– 

698 and 731–TA–1643–1657 

(Preliminary) pursuant to the Tariff Act 

of 1930 (‘‘the Act’’) to determine 

whether there is a reasonable indication 

that an industry in the United States is 

materially injured or threatened with 

material injury, or the establishment of 

an industry in the United States is 

materially retarded, by reason of 

imports of aluminum extrusions from 

China, Colombia, Dominican Republic, 

Ecuador, India, Indonesia, Italy, 

Malaysia, Mexico, South Korea, Taiwan, 

Thailand, Turkey, United Arab Emirates 

and Vietnam, provided for in 

subheadings 7604.10.10, 7604.10.30, 

7604.10.50, 7604.21.00, 7604.29.10, 

7604.29.30, 7604.29.50, 7608.10.00, 

7608.20.00, 7609.00.00, 7610.10.00, and 

7610.90.00 of the Harmonized Tariff 

Schedule of the United States, that are 

alleged to be sold in the United States 

at less than fair value and alleged to be 

subsidized by the Governments of 

China, Indonesia, Mexico, and Turkey. 

Unless the Department of Commerce 

(‘‘Commerce’’) extends the time for 

initiation, the Commission must reach a 

preliminary determination in 

antidumping and countervailing duty 

investigations in 45 days, or in this case 

by November 20, 2023. The 

Commission’s views must be 

transmitted to Commerce within five 

business days thereafter, or by 

November 28, 2023. 

DATES: October 4, 2023. 

FOR FURTHER INFORMATION CONTACT: 

Jordan Harriman ((202) 205–2610), 

Office of Investigations, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436. 

Hearing-impaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

these investigations may be viewed on 

the Commission’s electronic docket 

(EDIS) at https://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: 

Background.—These investigations 

are being instituted, pursuant to 

sections 703(a) and 733(a) of the Tariff 

Act of 1930 (19 U.S.C. 1671b(a) and 

1673b(a)), in response to a petition filed 

on October 4, 2023, by the U.S. 

Aluminum Extruders Coalition 

(consisting of Alexandria Extrusion 

Company, Alexandria, Minnesota; APEL 

Extrusions Inc., Coburg, Oregon; 

Bonnell Aluminum, Newnan, Georgia; 

Brazeway, Adrian, Michigan; Custom 

Aluminum Products, South Elgin, 

Illinois; Extrudex Aluminum, North 

Jackson, Ohio; International Extrusions, 

Garden City, Michigan; Jordan 

Aluminum Company, Memphis, 

Tennessee; M–D Building Products, 

Oklahoma City, Oklahoma; Merit 

Aluminum, Corona, California; MI 

Metals, Oldsmar, Florida; Pennex 

Aluminum, Wellsville, Pennsylvania; 

Tower Extrusions, Olney, Texas; and 

Western Extrusions, Carrollton, Texas) 

and the United Steel, Paper and 

Forestry, Rubber, Manufacturing, 

Energy, Allied Industrial and Service 

Workers International Union, 

Pittsburgh, Pennsylvania. 

For further information concerning 

the conduct of these investigations and 

rules of general application, consult the 

Commission’s Rules of Practice and 

Procedure, part 201, subparts A and B 

(19 CFR part 201), and part 207, 

subparts A and B (19 CFR part 207). 

Participation in the investigations and 

public service list.—Persons (other than 

petitioners) wishing to participate in the 

investigations as parties must file an 

entry of appearance with the Secretary 

to the Commission, as provided in 

§§ 201.11 and 207.10 of the 

Commission’s rules, not later than seven 

days after publication of this notice in 

the Federal Register. Industrial users 

and (if the merchandise under 

investigation is sold at the retail level) 

representative consumer organizations 

have the right to appear as parties in 

Commission antidumping duty and 

countervailing duty investigations. The 

Secretary will prepare a public service 

list containing the names and addresses 

of all persons, or their representatives, 

who are parties to these investigations 

upon the expiration of the period for 

filing entries of appearance. 

Limited disclosure of business 

proprietary information (BPI) under an 

administrative protective order (APO) 

and BPI service list.—Pursuant to 

§ 207.7(a) of the Commission’s rules, the 

Secretary will make BPI gathered in 

these investigations available to 

authorized applicants representing 

interested parties (as defined in 19 

U.S.C. 1677(9)) who are parties to the 

investigations under the APO issued in 

the investigations, provided that the 

application is made not later than seven 

days after the publication of this notice 

in the Federal Register. A separate 

service list will be maintained by the 

Secretary for those parties authorized to 

receive BPI under the APO. 

Conference.—The Office of 

Investigations will hold a staff 

conference in connection with the 

preliminary phase of these 

investigations beginning at 9:30 a.m. on 

Wednesday, October 25, 2023. Requests 

to appear at the conference should be 

emailed to preliminaryconferences@

usitc.gov (DO NOT FILE ON EDIS) on or 

before October 23, 2023. Please provide 

an email address for each conference 

participant in the email. Information on 

conference procedures, format, and 

participation will be available on the 

Commission’s Public Calendar. A 

nonparty who has testimony that may 

aid the Commission’s deliberations may 

request permission to participate by 

submitting a short statement. 

Please note the Secretary’s Office will 

accept only electronic filings during this 

time. Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov). No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. 

Written submissions.—As provided in 

§§ 201.8 and 207.15 of the 

Commission’s rules, any person may 

submit to the Commission on or before 

5:15 p.m. on October 30, 2023, a written 

brief containing information and 

arguments pertinent to the subject 

matter of the investigations. Parties shall 

file written testimony and 

supplementary material in connection 

with their presentation at the conference 

no later than noon on October 24, 2023. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices 71021 

All written submissions must conform 

with the provisions of § 201.8 of the 

Commission’s rules; any submissions 

that contain BPI must also conform with 

the requirements of §§ 201.6, 207.3, and 

207.7 of the Commission’s rules. The 

Commission’s Handbook on Filing 

Procedures, available on the 

Commission’s website at https://

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf, elaborates 

upon the Commission’s procedures with 

respect to filings. 

In accordance with §§ 201.16(c) and 

207.3 of the rules, each document filed 

by a party to the investigations must be 

served on all other parties to the 

investigations (as identified by either 

the public or BPI service list), and a 

certificate of service must be timely 

filed. The Secretary will not accept a 

document for filing without a certificate 

of service. 

Certification.—Pursuant to § 207.3 of 

the Commission’s rules, any person 

submitting information to the 

Commission in connection with these 

investigations must certify that the 

information is accurate and complete to 

the best of the submitter’s knowledge. In 

making the certification, the submitter 

will acknowledge that any information 

that it submits to the Commission 

during these investigations may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of these or related investigations or 

reviews, or (b) in internal investigations, 

audits, reviews, and evaluations relating 

to the programs, personnel, and 

operations of the Commission including 

under 5 U.S.C. Appendix 3; or (ii) by 

U.S. government employees and 

contract personnel, solely for 

cybersecurity purposes. All contract 

personnel will sign appropriate 

nondisclosure agreements. 

Authority: These investigations are 

being conducted under authority of title 

VII of the Tariff Act of 1930; this notice 

is published pursuant to § 207.12 of the 

Commission’s rules. 

By order of the Commission. 

Issued: October 5, 2023. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2023–22519 Filed 10–12–23; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1280] 

Bulk Manufacturer of Controlled 

Substances Application: Chattem 

Chemicals, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Chattem Chemicals, Inc., has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before December 12, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before December 12, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on July 14, 2023, Chattem 

Chemicals, Inc. 3801 Saint Elmo 

Avenue, Chattanooga, Tennessee 37409, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

4-Methoxyamphetamine .................................................................................................................................................. 7411 I 

Dihydromorphine ............................................................................................................................................................. 9145 I 

Amphetamine ................................................................................................................................................................... 1100 II 

Methamphetamine ........................................................................................................................................................... 1105 II 

Lisdexamfetamine ............................................................................................................................................................ 1205 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Cocaine ............................................................................................................................................................................ 9041 II 

Codeine ........................................................................................................................................................................... 9050 II 

Dihydrocodeine ................................................................................................................................................................ 9120 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Morphine .......................................................................................................................................................................... 9300 II 

Oripavine ......................................................................................................................................................................... 9330 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Alfentanil .......................................................................................................................................................................... 9737 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Tapentadol ....................................................................................................................................................................... 9780 II 


lotter on DSK11XQN23PROD with NOTICES1